ArdorComm Media Group

Contact Us
Tuesday, August 19, 2025 8:13 PM
logo
Menu
logo

Health & Wellness Community

HMPV Alert: States Intensify Monitoring as First Cases Reported in Bengaluru

Leave a Comment / / Health & Wellness Community

India has reported its first two cases of Human Metapneumovirus (HMPV) in Bengaluru, prompting several states, including Delhi, Maharashtra, and Telangana, to issue health advisories and strengthen surveillance measures. The cases involve two infants—a three-month-old who has been discharged and an eight-month-old currently under treatment. Neither child has a history of international travel, indicating local transmission. HMPV, a respiratory virus similar to the common cold, poses significant risks to vulnerable groups such as infants, the elderly, and those with compromised immune systems. Severe cases can lead to pneumonia or exacerbate pre-existing respiratory conditions. State-Wise Response and Precautions: Delhi: Health authorities have issued guidelines emphasizing reporting Influenza-like Illness (ILI) and Severe Acute Respiratory Infection (SARI) cases through the Integrated Health Information Platform (IHIP). Hospitals are urged to implement strict monitoring and isolation protocols. Maharashtra: The state is enhancing vigilance of SARI and ILI cases, assuring the public that the situation is under control. Kerala: Health Minister Veena George advised high-risk groups, including pregnant women, children, and the elderly, to wear masks and adopt preventive measures. Telangana and Andhra Pradesh: Both states have heightened monitoring and issued public advisories on basic precautions. Andhra Pradesh’s Director of Public Health, Dr. Padmavathi, emphasized the importance of staying informed and adopting simple safety measures. The Union Health Ministry has also reassured citizens there is no cause for panic, urging the public to follow preventive practices similar to those for other respiratory illnesses, such as wearing masks, maintaining hand hygiene, and avoiding crowded spaces. What is HMPV? Human Metapneumovirus (HMPV) is a respiratory virus that spreads through droplets and contact with contaminated surfaces. It commonly causes mild symptoms, including coughing, wheezing, sore throat, and a runny nose. However, in infants, elderly individuals, and immunocompromised patients, the virus can lead to severe complications, such as pneumonia or acute respiratory distress, necessitating immediate medical attention. While unrelated to COVID-19, HMPV shares similar transmission methods and requires preventive measures to curb its spread. With heightened awareness and proactive measures, health authorities aim to mitigate the risks associated with the virus. Source: Business Standard Photo Credit: Business Standard

HMPV Alert: States Intensify Monitoring as First Cases Reported in Bengaluru Read More »

UN: Israeli Attacks Threaten Total Collapse of Gaza Healthcare System

Leave a Comment / / Health & Wellness Community

The United Nations Human Rights Office (OHCHR) has warned that Israeli military actions in Gaza have pushed the region’s healthcare system to “the brink of total collapse.” In a report, the UN documented attacks on hospitals and medical facilities, raising concerns about possible war crimes and violations of international humanitarian law. The report outlines a troubling pattern of strikes, sieges, and forced evacuations of hospitals, resulting in significant casualties among patients and medical personnel. It acknowledges Israel’s claims that Palestinian armed groups have misused hospitals, but labels the evidence supporting these allegations as “vague” and sometimes contradictory. Volker Türk, UN High Commissioner for Human Rights, condemned the attacks, emphasizing the paramount importance of protecting healthcare facilities during conflict. “The protection of hospitals during warfare is paramount and must be respected by all sides, at all times,” he stated. Since October 2023, at least 136 strikes on 27 of Gaza’s 38 hospitals have been documented, causing severe damage and the deaths of over 500 medical professionals. The OHCHR report highlights the broader impacts of the conflict, including rising maternal and child mortality due to lack of care, and numerous deaths from delayed treatment of trauma injuries. The Israeli government responded by asserting that it had taken measures to minimize civilian harm, including establishing evacuation routes and providing aid to hospitals. It also accused Hamas of using medical facilities as shields for military operations, claims the UN says remain unsubstantiated. Türk called for independent investigations into the incidents and urged Israel, as the occupying power, to prioritize the facilitation of healthcare for the Palestinian population. The report adds to the growing international scrutiny of the ongoing conflict and its humanitarian toll. Source: BBC Photo Credit: BBC

UN: Israeli Attacks Threaten Total Collapse of Gaza Healthcare System Read More »

Reliance Acquires Oncology Platform Karkinos Healthcare for ₹375 Crore

Leave a Comment / / Health & Wellness Community

Reliance Industries Limited (RIL), led by billionaire Mukesh Ambani, has acquired Karkinos Healthcare Pvt Ltd, a technology-driven oncology platform, for ₹375 crore. The acquisition, conducted through Reliance Strategic Business Ventures Ltd (RSBVL), a wholly-owned subsidiary of RIL, was finalized with the allotment of 1 crore equity shares and 36.5 crore optionally fully convertible debentures, according to a stock exchange filing on Saturday. Founded on July 24, 2020, Karkinos Healthcare focuses on innovative solutions for the early detection, diagnosis, and management of cancer. The company recorded a turnover of ₹22 crore in FY 2022-23 and has collaborated with approximately 60 hospitals by December 2023. Karkinos also operates through a subsidiary to establish a 150-bed multispecialty cancer hospital in Imphal, Manipur. Prominent previous investors in Karkinos included Ewart Investments (a Tata Sons subsidiary), Reliance Digital Health, the US-based Mayo Clinic, and industry stalwarts like Sundar Raman and Ravi Kant. The company’s offerings span Advanced Cancer Care Diagnostics and Research (ACCDR), a Distributed Cancer Care Network (DCCN), and corporate tie-ups for early cancer diagnosis. The acquisition comes as part of Reliance’s strategic expansion into the healthcare sector. “The acquisition of Karkinos will help expand the health services business portfolio of the Reliance group,” the company stated. The National Company Law Tribunal (NCLT), Mumbai Bench, had approved the resolution plan for Karkinos under the Corporate Insolvency Resolution Process in December 2024, allowing Reliance to proceed without additional regulatory approvals. This move aligns with Reliance’s vision to integrate innovative, cost-effective healthcare solutions into its growing portfolio, positioning itself as a significant player in the Indian healthcare industry. Source: Economic Times Photo Credit: Economic Times  

Reliance Acquires Oncology Platform Karkinos Healthcare for ₹375 Crore Read More »

Yemen Reports 35% of Global Cholera Cases Amid Severe Humanitarian Crisis

Leave a Comment / / Health & Wellness Community

Yemen is grappling with a catastrophic cholera outbreak, accounting for 35% of global cases in 2024. The World Health Organization (WHO) reported 249,900 suspected cases and 861 deaths as of December 1, marking a 37% increase in infections and a 27% rise in fatalities compared to 2023. Arturo Pesigan, WHO’s Representative in Yemen, described the crisis as a severe strain on the nation’s healthcare system. “This outbreak of waterborne diseases like cholera adds further pressure to an already overstretched health system facing multiple disease outbreaks,” Pesigan stated. The epidemic is driven by a lack of clean water, poor sanitation, and inadequate medical facilities. Over 18.2 million Yemenis require humanitarian assistance, and 17.6 million face food insecurity. Among children under five, nearly half suffer from moderate to severe stunting due to malnutrition, exacerbating the outbreak’s impact. Yemen’s healthcare system, battered by years of conflict, has struggled to respond. Cholera, caused by ingesting contaminated water or food, has persisted since its largest outbreak from 2017 to 2020, which saw over 2.5 million cases and 4,000 deaths. The response efforts are critically underfunded, with a $20 million gap in funding for October 2024 to March 2025. This shortfall has led to the closure of 47 diarrhoea treatment centres (DTCs) and 234 oral rehydration centres (ORCs), with more closures anticipated by year-end, potentially eliminating 84% of DTCs nationwide. To control the epidemic, WHO has called for immediate measures, including oral cholera vaccination campaigns, improved disease surveillance, expanded treatment services, and water, sanitation, and hygiene (WASH) initiatives. The ongoing crisis underscores the toll of prolonged conflict and neglect in Yemen, highlighting the urgent need for international solidarity to address systemic issues in water, sanitation, and healthcare access. Source: Newsx Photo Credit: Newsx

Yemen Reports 35% of Global Cholera Cases Amid Severe Humanitarian Crisis Read More »

Mpox Cases in Africa Near 70,000 Mark: Africa CDC Calls for Urgent Action

Leave a Comment / / Health & Wellness Community

The Africa Centers for Disease Control and Prevention (Africa CDC) has reported a significant rise in mpox cases across the continent, with the total number surpassing 69,000 this year and fatalities exceeding 1,260. These alarming statistics were shared by Ngashi Ngongo, Chief of Staff at Africa CDC, during an online media briefing on Thursday. According to Africa CDC data, as of this year, 69,211 cases have been reported, including 14,794 confirmed infections and 1,268 deaths. Last week alone saw 3,095 new cases, with 553 confirmed and 31 additional deaths, marking a 789% increase in confirmed cases compared to 2023. Fifteen African countries currently face active mpox transmission, while five nations—Gabon, South Africa, Morocco, Zambia, and Zimbabwe—have recently transitioned to controlled stages of the outbreak. Ngongo emphasized the urgency of intensifying resource mobilization, expanding vaccination campaigns, and enhancing integrated response strategies. Other priorities highlighted by Africa CDC include improving data management systems and addressing co-infections, as 20 African nations remain affected by the outbreak. Ngongo called for collaboration among countries to share best practices and bolster efforts to contain the epidemic. The mpox outbreak was declared a public health emergency of continental security by Africa CDC in mid-August, shortly followed by the World Health Organization designating it a public health emergency of international concern. This marks only the second time in two years that WHO has issued its highest-level alert for the disease. First identified in laboratory monkeys in 1958, mpox—formerly known as monkeypox—is a rare viral disease that spreads through body fluids, respiratory droplets, and contaminated materials. Symptoms include fever, rash, and swollen lymph nodes, posing severe risks to public health in Africa and beyond. Source: Nagalandpost Photo Credit: Nagalandpost

Mpox Cases in Africa Near 70,000 Mark: Africa CDC Calls for Urgent Action Read More »

First Severe U.S. Human Case of H5N1 Bird Flu Reported in Louisiana

Leave a Comment / / Health & Wellness Community

The United States has recorded its first severe human case of H5N1 bird flu, with a Louisiana resident hospitalized after exposure to sick and dead birds in backyard flocks. This case, confirmed by the Centers for Disease Control and Prevention (CDC), marks the first U.S. human infection linked to backyard poultry. Key Highlights: Case Details: The Louisiana patient was exposed to infected birds but symptoms remain undisclosed. This case is part of a broader trend, with over 60 bird flu infections reported in 2023, more than half in California. Undetermined Cases in Other States: Health officials are investigating two additional cases—a Missouri adult and a California child—where the source of infection remains unclear. No Person-to-Person Transmission: Officials have emphasized that bird flu remains primarily an animal health issue. Importantly, there is no documented spread of H5N1 from person to person, keeping the risk to the general public low. Prevention Measures: To reduce the risk of H5 bird flu infection: Avoid exposure to sick or dead birds. Be cautious around backyard poultry flocks. Practice good hygiene if handling birds or their byproducts. Infected birds can shed the virus through saliva, mucous, and feces, while other animals may spread the virus through respiratory secretions. Health officials continue to monitor the situation closely, reaffirming that the risk to the public is minimal but urging caution in handling potentially infected birds. Source: India Today Photo Credit: India Today

First Severe U.S. Human Case of H5N1 Bird Flu Reported in Louisiana Read More »

UAE Healthcare Sets Global Benchmark in Preventive Medicine: M42 CEO

Leave a Comment / / Health & Wellness Community

Abu Dhabi, UAE: The UAE healthcare system has established itself as a global leader in preventive medicine, driven by cutting-edge technology, genomic research, and AI-powered healthcare solutions. Speaking to the Emirates News Agency (WAM), Hasan Jasem Al Nowais, Managing Director and Group CEO of M42, highlighted the nation’s advancements underpinned by visionary leadership and collaborative innovation. Driving Healthcare Innovation Al Nowais credited the UAE’s leadership for fostering an ecosystem that integrates advanced hospitals, robotic technologies, genomic science, and artificial intelligence, enabling a shift from reactive treatment to proactive health management. He underscored M42’s collaboration with government entities to revolutionize healthcare by focusing on: Early detection of health risks through data-driven insights Delivering targeted treatments more efficiently Reducing healthcare costs while improving outcomes M42’s Vision for Preventive Care M42 is committed to shifting healthcare paradigms by prioritizing precision, preventive, and predictive medicine. The group also aims to enhance healthy ageing, promote general well-being, and transition to a more sustainable healthcare model. “For meaningful, lasting, and positive change that enhances human longevity worldwide, we must collectively focus on three pillars: precision, preventive, and predictive medicine,” Al Nowais stated, emphasizing the role of AI and genomic science in detecting diseases before symptoms arise. Innovative AI Solutions M42 has introduced several groundbreaking healthcare innovations: Med42: An open-source, large clinical language model AIRIS-TB: An AI-powered system capable of conducting 2,000 chest X-rays daily to combat tuberculosis—ten times the capacity of traditional methods AI in Endoscopy: Enhances the detection of abnormalities and early signs of cancer These technologies signify a leap in diagnostic efficiency and precision, paving the way for personalized care. Genomics and the UAE Genome Programme M42’s Omics Centre of Excellence is spearheading genomic research, including the UAE Genome Programme, which aims to advance precision medicine and proactive health management. These initiatives are crucial for identifying genetic predispositions to diseases, further strengthening the UAE’s position as a leader in genomics-driven preventive healthcare. Global Inspiration Al Nowais concluded by highlighting the UAE’s commitment to setting new global standards in healthcare. Through innovations in AI, genomic science, and cross-sector collaboration, the UAE is shaping a future where preventive medicine and sustainable healthcare become the norm, inspiring countries worldwide. Source: Business Standard Photo Credit: Business Standard

UAE Healthcare Sets Global Benchmark in Preventive Medicine: M42 CEO Read More »

Bain Capital Invests $157 Million in Indonesia’s Mayapada Healthcare

Leave a Comment / / Health & Wellness Community

U.S.-based private investment firm Bain Capital has announced a $157 million investment in Indonesia’s Mayapada Healthcare Group, known as Sejahteraraya Anugrahjaya Tbk PT (SRAJ.JK). The deal, part of Bain Capital’s special situations strategy, will support Mayapada’s hospital expansion through both organic growth and strategic initiatives. The investment is Bain Capital’s first in Indonesia, reflecting growing interest in Southeast Asia’s healthcare sector. The firm’s special situations team, managing over $20 billion in assets, combines credit and equity strategies to target high-growth opportunities. Jonathan Tahir, Mayapada’s chairman and Group CEO, highlighted the demographic trends fueling the healthcare market: “Indonesia faces a growing gap between healthcare supply and demand due to demographic shifts like an aging population and rising affluence.” Sarit Chopra, Bain Capital’s partner and head of special situations in Asia, expressed confidence in Mayapada’s potential, noting that the Indonesian private healthcare market is still in its early stages of development. Founded in 2008, Mayapada Healthcare Group operates seven hospitals across Indonesia, including a flagship hospital in South Jakarta with over 1,000 beds. The group plans to increase its capacity to over 2,000 beds by 2027, supported by ongoing projects. Shares of Mayapada Healthcare have soared 747% year-to-date, signaling strong market optimism. The transaction is expected to close in early 2025, subject to regulatory and shareholder approvals. With this investment, Bain Capital taps into Southeast Asia’s rising affluence and aging population, positioning itself in a resilient sector amid global economic challenges. Source: Reuters Photo Credit: Reuters  

Bain Capital Invests $157 Million in Indonesia’s Mayapada Healthcare Read More »

Over 1 in 5 Adults Worldwide Infected with Genital Herpes: WHO

Leave a Comment / / Health & Wellness Community

According to the World Health Organization (WHO), over 846 million people aged 15 to 49, or more than one in five individuals in this age group, are living with genital herpes infections globally. These findings, published in the journal Sexually Transmitted Infections, highlight the widespread nature of the infection and underscore the urgent need for improved prevention, treatment, and vaccine development. Each year, an estimated 42 million people contract a new genital herpes infection, equating to one new case every second. While many infections are asymptomatic, over 200 million individuals in 2020 experienced painful genital sores and blisters, often requiring repeated medical visits. Dr. Meg Doherty, WHO’s Director of Global HIV, Hepatitis, and STI Programmes, emphasized the strain on global health systems: “Genital herpes causes pain and distress for millions, and better prevention and treatment options are critical to controlling its spread and reducing its health impacts, including its link to an increased risk of HIV transmission.” The study estimates 520 million people have genital HSV-2, responsible for 90% of symptomatic cases and associated with a three-fold higher HIV risk. An additional 376 million are infected with genital HSV-1, which is increasingly transmitted during adulthood due to declining childhood oral infections. Herpes infections carry significant social and economic burdens. Stigma often silences discussions about the infection, and healthcare costs and productivity losses are estimated at $35 billion annually. WHO advocates consistent condom use and avoiding sexual contact during active outbreaks to reduce transmission. It also recommends HIV testing for individuals with genital herpes and pre-exposure prophylaxis when needed. Research into vaccines and new treatments remains a priority, as these advancements could significantly improve global health outcomes and reduce the stigma surrounding herpes infections. Source: World Health Organization Photo Credit: World Health Organization

Over 1 in 5 Adults Worldwide Infected with Genital Herpes: WHO Read More »

Max Healthcare Hits All-Time High Stock Price of ₹1124.9

Leave a Comment / / Health & Wellness Community

Max Healthcare Institute, a leading provider in the hospital and healthcare services sector, achieved a significant milestone as its stock price reached an all-time high of ₹1124.9 on December 10, 2024. This impressive performance underscores the company’s strong market position and growth potential. Key Highlights Stock Performance: The stock has shown a 15.49% gain over the past 7 days, maintaining consistent upward momentum. Current Recommendation: MarketsMojo has issued a ‘Hold’ call for Max Healthcare, reflecting its steady alignment with the broader market trends. Moving Averages: The stock price exceeds its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signaling strong technical performance. Comparative Growth Max Healthcare’s 1-year performance of 64.79% stands out significantly against the Sensex’s 16.72% growth over the same period. This remarkable growth reinforces the company’s robust standing in the healthcare sector. Market Stability The stock’s consistent trading price and long-term upward trajectory highlight its stability and appeal as a reliable investment option. Industry Leadership As a large-cap entity, Max Healthcare Institute continues to set benchmarks in the healthcare services industry, showcasing profitability and resilience. With its current trajectory, the company remains well-positioned for sustained success and growth in the future. Investors and market analysts are closely watching Max Healthcare, which has emerged as a top contender in the healthcare sector, offering both stability and promising returns. Source: marketsmojo Photo Credit: marketsmojo

Max Healthcare Hits All-Time High Stock Price of ₹1124.9 Read More »